Diazepam Richter (Diazepam)

Diazepam Richter is prescribed for several clinical conditions that benefit from its anxiolytic, anticonvulsant, muscle‑relaxant, and sedative properties.

• Management of generalized anxiety disorder and related anxiety conditions.
• Adjunctive therapy for seizure disorders, including status epilepticus.
• Relief of muscle spasm associated with musculoskeletal injuries.
• Treatment of alcohol withdrawal syndrome.
• Short‑term pre‑operative sedation and anxiolysis when indicated.

Diazepam Richter may cause a range of side effects, most of which are dose‑dependent and reversible upon discontinuation.

Common

• Drowsiness or fatigue
• Dizziness or light‑headedness
• Impaired coordination or ataxia
• Memory impairment (anterograde amnesia)
• Slurred speech
• Visual disturbances (blurred vision)

Serious

• Respiratory depression, especially with CNS depressants
• Severe hypotension
• Paradoxical aggression or agitation
• Dependence, tolerance, and withdrawal syndrome
• Hepatic dysfunction in patients with pre‑existing liver disease
• Allergic reactions such as rash, angioedema, or anaphylaxis

Before initiating therapy with Diazepam Richter, clinicians should evaluate several safety considerations.

• Assess for a history of substance use disorder or dependence.
• Use cautiously in patients with respiratory disorders, such as COPD or sleep apnea.
• Adjust dose or monitor closely in hepatic or renal impairment.
• Avoid abrupt discontinuation; taper gradually to prevent withdrawal seizures.
• Counsel pregnant women about potential fetal risk (Category D).
• Evaluate for concomitant CNS depressants that may enhance sedation.

Diazepam Richter can interact with a variety of medications, altering its efficacy or safety profile.

Avoid

• Opioids, barbiturates, or other benzodiazepines due to additive respiratory depression.
• Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin) which increase plasma levels.
• Alcohol, which markedly enhances sedative effects.

Use with caution

• CYP2C19 inhibitors (e.g., fluoxetine) that may modestly raise concentrations.
• Antidepressants, especially SSRIs, that can increase risk of serotonin syndrome.
• Antihistamines and anticholinergics that may exacerbate cognitive impairment.
• Anticonvulsants such as phenytoin, which may reduce diazepam effectiveness.